The impact of Disopyramide on exercise capacity in Hypertrophic Cardiomyopathy: it is not all about relieving obstruction.
Anno:
2024
INTRODUCTION Disopyramide has been extensively utilized since the late 1980s to decrease obstruction and improve symptoms in patients with obstructive hypertrophic cardiomyopathy (oHCM). Nevertheless, there is currently no evidence about the impact of this drug on functional capacity assessed with cardiopulmonary exercise test (CPET). AIM To investigate the impact…